Early in the COVID-19 pandemic, when America’s frontline medical workers were desperate to get a hold of crucial medical gear, a Texas-based mobile health company paid roughly $500,000 for 100,000 antibody test kits from China—the only place at the time that was selling these much needed products.
But the kits, which would have been used to fill orders from the U.S. military and their state customers, never went further than the company’s warehouse where the products were delivered before July, 2020, following months of delays after a product test by the importer said it found a concerning number of the tests to be defective….